01
Why athletes ask
Metabolic flexibility and exercise models made MOTS-c famous. Fame is not availability.
- ·Mitochondrial peptide
- ·Not a legal workout drug
- ·Not orderable
RE GEN RX · peptides / MOTS-c
Under FDA review
MOTS-c
A mitochondrial peptide PCAC recommended — not orderable until FDA lists it.
Oswego, Illinois · 74 W. Washington St · serving the Fox Valley. A licensed Illinois clinician still decides. Compounded medications are not FDA-approved.
Legal status reviewed July 2026 · Mitochondrial peptide
What is MOTS-c?
The molecule, in plain language.
MOTS-c is a mitochondrial-encoded peptide studied for metabolic and exercise-related signaling. PCAC recommended it for the 503A bulks list in July 2026. RE GEN will not compound it on a vote.
How people usually take it. Not orderable today.
What people are actually trying to solve.
Interest is not a result. We keep the research language and skip the miracle.
02
July 2026
Recommended with several other peptides. Recommendation is not rulemaking.
- ·Advisory only
- ·We will not gray-market a bridge
- ·Check this page later for FDA action
03
Carried mitochondrial support
NAD+ protocols exist when a clinician decides they fit.
- ·NAD+ page
- ·GLP-1 if weight is the real goal
- ·Consult
What the evidence actually is — and what it isn’t.
A note on honesty: we will tell you what the literature supports and what it does not. Animal data is not a human guarantee. Anecdotes are not trials.
Animal research
MOTS-c has preclinical metabolic and exercise literature.
- ·Mitochondrial signaling
- ·Not 503A listing yet
- ·Not orderable
Human research
Human data are still emerging. PCAC recommendation is not approval.
- ·Not orderable
- ·No performance guarantee in any case
- ·Do not buy research MOTS-c
Legal basis at RE GEN · July 2026
We will not compound this today.
PCAC recommended MOTS-c for the 503A bulks list in July 2026. Not orderable at RE GEN until FDA acts.
PCAC recommended listing is not a green light. Not orderable today.
Common questions
Peptide education for Illinois patients at RE GEN in Oswego — not a substitute for a visit.
What is MOTS-c?
A mitochondrial-encoded peptide studied in metabolic research. PCAC recommended listing in July 2026. Not orderable yet.
Is MOTS-c FDA-approved?
MOTS-c is not FDA-approved, and RE GEN does not have a lawful §503A pathway to request it as a compounded medication today. A committee vote is not approval.
Can I get MOTS-c at RE GEN in Oswego?
You can start a visit to talk about your goal. We will not compound MOTS-c today. We will show you what is carried instead — and we will say no rather than gray-market a vial.
Is it a GLP-1?
No. Different biology. If weight is the goal, read the GLP-1 pages.
Do you promise results?
No. Educational pages explain why people ask and what the research landscape looks like. Individual response varies. Compounded medications are not FDA-approved, and a request is not a guaranteed prescription.
Related on this menu
Illinois practice · licensed 503A compounding
A committee vote is not a green light. We add a peptide when FDA does.
Hello Gorgeous PC · 74 W. Washington St, Oswego, IL
RE GEN desk 630-636-6193
Start a visit, a licensed Illinois clinician reviews, then you pay the invoice. If they don't prescribe, we refund.